IGF1 and retinopathy of prematurity: This is supported by rodent studies demonstrating that pharmacological inhibition of IGF-1 prevents VEGF pathway activation, oxygen-mediated vessel loss, and subsequent neovascularization in the OIR model of ROP, suggesting a permissive role of IGF-1 in VEGF-mediated retinal neovascularization [69, 70].